Human enteric nervous system progenitor transplantation improves functional responses in Hirschsprung disease patient-derived tissue
Open Access
Abstract
Objective Hirschsprung disease (HSCR) is a severe congenital disorder affecting 1:5000 live births. HSCR results from the failure of enteric nervous system (ENS) progenitors to fully colonise the gastrointestinal tract during embryonic development. This leads to aganglionosis in the distal bowel, resulting in disrupted motor activity and impaired peristalsis. Currently, the only viable treatment option is surgical resection of the aganglionic bowel. However, patients frequently suffer debilitating, lifelong symptoms, with multiple surgical procedures often necessary. Hence, alternative treatment options are crucial. An attractive strategy involves the transplantation of ENS progenitors generated from human pluripotent stem cells (hPSCs). Design ENS progenitors were generated from hPSCs using an accelerated protocol and characterised, in detail, through a combination of single-cell RNA sequencing, protein expression analysis and calcium imaging. We tested ENS progenitors’ capacity to integrate and affect functional responses in HSCR colon, after ex vivo transplantation to organotypically cultured patient-derived colonic tissue, using organ bath contractility. Results We found that our protocol consistently gives rise to high yields of a cell population exhibiting transcriptional and functional hallmarks of early ENS progenitors. Following transplantation, hPSC-derived ENS progenitors integrate, migrate and form neurons/glia within explanted human HSCR colon samples. Importantly, the transplanted HSCR tissue displayed significantly increased basal contractile activity and increased responses to electrical stimulation compared with control tissue. Conclusion Our findings demonstrate, for the first time, the potential of hPSC-derived ENS progenitors to repopulate and increase functional responses in human HSCR patient colonic tissue.Keywords
Funding Information
- Horizon 2020 Framework Programme (824070)
- Medical Research Council (MR/V002163/1)
- National Centre for the Replacement Refinement and Reduction of Animals in Research (NC/V001078/1)
This publication has 53 references indexed in Scilit:
- hPSC-derived sacral neural crest enables rescue in a severe model of Hirschsprung’s diseaseCell Stem Cell, 2023
- Hirschsprung disease outcomesSeminars in Pediatric Surgery, 2022
- Long-term surgical and patient-reported outcomes of Hirschsprung DiseaseJournal of Pediatric Surgery, 2021
- Generating Enteric Nervous System Progenitors from Human Pluripotent Stem CellsCurrent Protocols, 2021
- Guidelines for the management of postoperative soiling in children with Hirschsprung diseasePediatric Surgery International, 2019
- Enteric Neural Cells From Hirschsprung Disease Patients Form Ganglia in Autologous Aneuronal ColonCellular and Molecular Gastroenterology and Hepatology, 2016
- Transplantation of amniotic fluid-derived neural stem cells as a potential novel therapy for Hirschsprung's diseaseJournal of Pediatric Surgery, 2015
- RET gene is a major risk factor for Hirschsprung’s disease: a meta-analysisPediatric Surgery International, 2015
- Successful Function of Autologous iPSC-Derived Dopamine Neurons following Transplantation in a Non-Human Primate Model of Parkinson’s DiseaseCell Stem Cell, 2015
- Sorting out Sox10 functions in neural crest developmentBioEssays, 2006